Delos Wealth Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-5
Closed -$114 381
2023
Q3
$114 Hold
5
﹤0.01% 364
2023
Q2
$127 Hold
5
﹤0.01% 362
2023
Q1
$130 Hold
5
﹤0.01% 375
2022
Q4
$118 Hold
5
﹤0.01% 384
2022
Q3
$0 Hold
5
﹤0.01% 377
2022
Q2
$0 Hold
5
﹤0.01% 261
2022
Q1
$0 Hold
5
﹤0.01% 411
2021
Q4
$0 Hold
5
﹤0.01% 474
2021
Q3
$1K Hold
5
﹤0.01% 196
2021
Q2
$1K Buy
+5
New +$810 ﹤0.01% 177

Other funds holding TDOC

Delos Wealth Advisors's TDOC Position: Q4 2023 in Review

Delos Wealth Advisors sold out of Teladoc Health (TDOC) in Q4 2023, closing a stake of 5 shares — an estimated $114 sold.

Delos Wealth Advisors first reported a position in TDOC in Q2 2021 and held it in 10 quarters. The position peaked at $1K in Q3 2021. 435 funds tracked by Wall St. Rank hold TDOC as of Q4 2023.

  • Delos Wealth Advisors reported no remaining Teladoc Health position as of Q4 2023 after selling out during the quarter.
  • Delos Wealth Advisors sold 5 Teladoc Health shares in Q4 2023, an estimated $114.
  • Delos Wealth Advisors first reported a position in Teladoc Health in Q2 2021 and held it in 10 quarters.
  • Delos Wealth Advisors's Teladoc Health position peaked at $1K in Q3 2021.
  • 435 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2023.

Based on Delos Wealth Advisors's 13F filing for Q4 2023, filed 7 Feb 2024.